The Impact of The Microbiome on Drug Efficacy
DOI:
https://doi.org/10.58445/rars.1600Keywords:
drug metabolism, gut microbiome, pharmacomicrobiomics, Personalized MedicineAbstract
The human gut microbiome plays a critical role in modulating drug efficacy and toxicity, representing a significant frontier in personalized medicine. Recent studies have elucidated the intricate interactions between gut microbiota and pharmaceuticals, revealing that the microbiome can influence drug metabolism, bioavailability, and therapeutic outcomes. For instance, it has been shown that various non-antibiotic drugs can alter the composition and function of gut bacteria, which in turn can modify the pharmacokinetics and pharmacodynamics of these drugs .This bidirectional relationship underscores the importance of considering microbiome composition when evaluating drug responses, as individual variations in gut microbiota can lead to significant differences in drug efficacy and side effects . Research has demonstrated that specific gut bacteria possess the enzymatic capacity to metabolize a wide range of drugs, impacting their activation and degradation . For example, the metabolism of prodrugs, which require biotransformation to exert their therapeutic effects, is heavily reliant on microbial activity . Furthermore, the expression of drug-metabolizing enzymes in the liver can also be influenced by gut microbiota, highlighting a complex interplay between the microbiome and host metabolism .The implications of these interactions are profound, as they can inform drug development processes and therapeutic strategies aimed at optimizing drug efficacy while minimizing adverse effects. Emerging evidence suggests that the integration of microbiome profiling into pharmacotherapy could enhance treatment precision. By identifying microbiome-related biomarkers, clinicians may be able to predict individual responses to medications, thereby tailoring therapies to improve outcome . Additionally, understanding the mechanisms by which the microbiome alters drug metabolism could pave the way for novel interventions, such as microbiome-targeted therapies that enhance drug efficacy or mitigate side effects.
References
Cussotto, S., Walsh, J., Golubeva, A. V., Zhdanov, A. V., Strain, C., Fouhy, F., … & Griffin, B. T. (2021). The gut microbiome influences the bioavailability of olanzapine in rats. eBioMedicine, 66, 103307. https://doi.org/10.1016/j.ebiom.2021.103307 Enright, E. F., Gahan, C. G., Joyce, S. A., & Griffin, B. T. (2016). Focus: microbiome: the impact of the gut microbiota on drug metabolism and clinical outcome. The Yale journal of biology and medicine, 89(3), 375. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045146/
Guthrie, L., & Kelly, L. (2019). Bringing microbiome-drug interaction research into the clinic. EBioMedicine, 44, 708-715.https://www.thelancet.com/article/S2352-3964(19)30310-X/fulltext
Javdan, B., Lopez, J. G., Chankhamjon, P., Lee, Y. C. J., Hull, R., Wu, Q., … & Donia, M. S. (2020). Personalized mapping of drug metabolism by the human gut microbiome. Cell, 181(7), 1661-1679.e22. https://doi.org/10.1016/j.cell.2020.05.001 Lee-Sarwar, K. A., Lasky-Su, J., Kelly, R. S., Litonjua, A. A., & Weiss, S. T. (2020). Metabolome–microbiome crosstalk and human disease. Metabolites, 10(5), 181. https://www.mdpi.com/2218-1989/10/5/181
Ling, H., Foo, J L., Saxena, G., & Swarup, S. (2017, March 18). Drug Targeting of the Human Microbiome. https://scite.ai/reports/drug-targeting-of-the-human-lLvQrm
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., … & Typas, A. (2018). Extensive impact of non-antibiotic drugs on human gut bacteria. Nature, 555(7698), 623-628.https://doi.org/10.1038/nature25979 Swanson, H. I. (2015). Drug metabolism by the host and gut microbiota: a partnership or rivalry?. Drug Metabolism and Disposition, 43(10), 1499-1504.https://doi.org/10.1124/dmd.115.065714
Undefined, U., & Undefined, U. (2017, January 1). Gut microbiome interactions with drug metabolism, efficacy, and toxicityhttps://scite.ai/reports/gut-microbiome-interactions-with-drug-X0enaw
Undefined, U., Undefined, U., Undefined, U., & Undefined, U. (2017, March 18). Drug Targeting of the Human Microbiomehttps://scite.ai/reports/drug-targeting-of-the-human-lLvQrm Walsh, J., Griffin, B. T., Clarke, G., & Hyland, N. P. (2018). Drug–gut microbiota interactions: implications for neuropharmacology. British Journal of Pharmacology, 175(24), 4415-4429.https://doi.org/10.1111/bph.14366
Wilson, I D., & Nicholson, J K. (2017, January 1). Gut microbiome interactions with drug metabolism, efficacy, and toxicity. https://scite.ai/reports/gut-microbiome-interactions-with-drug-X0enaw Wilson, I. D. and Nicholson, J. K. (2017). Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Translational Research, 179, 204-222.https://doi.org/10.1016/j.trsl.2016.08.002 Zimmermann, M., Patil, K. R., Typas, A., & Maier, L. (2021). Towards a mechanistic understanding of reciprocal drug–microbiome interactions. Molecular Systems Biology, 17(3). https://doi.org/10.15252/msb.202010116
Downloads
Posted
License
Copyright (c) 2024 Mazen Alashry
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.